GlobalData on MSN10h
Novo Nordisk and NanoVation sign $600m deal in rare and cardiometabolic diseasesNanoVation will receive $600m in upfront cash and potential milestone payments, as well as tiered royalties on future product ...
The agreement with NanoVation marks the second big recent deal that a B.C. biotech startup has struck with the Danish ...
Novo Nordisk is continuing its push into genetic medicines, agreeing to pay NanoVation Therapeutics up to $600 million to ...
Canada’s NanoVation Therapeutics has partnered with Novo Nordisk to advance genetic medicines for cardiometabolic and rare ...
The firms will collaborate on two lead programs and up to five future targets in other diseases, with NanoVation eligible for up to $600 million in payments from Novo Nordisk.
ME Therapeutics Holdings Inc. (CSE: METX) (FSE: Q9T) ("ME Therapeutics" or the "Company"), a preclinical stage biotechnology ...
The Federal Reserve yesterday cut interest rates by 50 basis points, in its first time cutting rates in four years. And how ...
Sep. 17, 2024 — A key step toward reusing CO2 to make sustainable fuels is chaining carbon atoms together, and an artificial photosynthesis system can bind two of ... Using Sunlight to Turn Two ...
US CDMO BioCentriq has appointed Syed Husain as its new CEO. Husain, who brings over 20 years of experience in CDMO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback